FDA Inspection 865872 — Paradox, Inc

Paradox, Inc — FEI 1927976

The FDA completed an inspection of Paradox, Inc on Feb 7, 2014 in Saint Joseph, MO. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI)
End Date
Feb 7, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Saint Joseph, MO (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.